LB Pharmaceuticals

tenant

drug

Goserelin 3.6 mg implant

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

small molecule

Pre-approval / investigational in the US

Developed by Gitte Moos Knudsen

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

small molecule

Indications

Investigational (via trials)

Schizophrenia Psychological Well-Being Neurodegeneration Schizophrenia Depressive Disorder, Major Major Depressive Disorder Nerve Degeneration Depression, Postpartum Postpartum Depression Postpartum Psychosis Coitus Menopause

Trials

1

Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression

NCT02661789—Completed

KOLs & investigators

1

Vibe G Frokjaer, MD, Phd

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Gitte Moos Knudsen

company

trial

Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression

NA

trial

indication

indication

Psychological Well-Being

indication

Neurodegeneration

indication

indication

KOL

Vibe G Frokjaer, MD, Phd

KOL score —

person